[Antiandrogen withdrawal syndrome in hormone refractory metastatic prostate cancer].
Coutant
G
G
Algayres
J P
JP
Dordain
M L
ML
Selle
F
F
Le Berruyer
P Y
PY
Bili
H
H
Daly
J P
JP
D000230:Adenocarcinoma / Q000188:drug therapy / Q000473:pathology* / Q000556:secondary; D000368:Aged; D000726:Androgen Antagonists / Q000009:adverse effects*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000556:secondary*; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D013375:Substance Withdrawal Syndrome
D000726:Androgen Antagonists; D017430:Prostate-Specific Antigen